Search

everythinglearnresearchcommunity

for

Search:↓

Umbilical cord and cord blood stem cells are promising for treating chronic diseases due to their versatility and ethical acceptability.

The human amniotic membrane is a promising material for skin treatments and hair growth.

Pregnancy can cause skin changes and conditions that need correct diagnosis and treatment for the health of the mother and baby.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Mesenchymal stem cells are key to future tissue regeneration in oral surgery.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

FOXN1 gene variants cause low T cells and immune issues from birth.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

Fat tissue stem cells show promise for repairing different body tissues and are being tested in clinical trials.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Induced pluripotent stem cells could improve chronic wound healing but face safety and effectiveness challenges.

Pregnancy-related skin disorders need accurate diagnosis and treatment to prevent risks to the baby.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.